Tulane University Health Sciences Center in N.O. Receives Grant to Study Lung Disease
Posted on: Monday, 8 August 2005, 03:01 CDT
The National Institutes of Health granted $800,000 to the Tulane University Health Sciences Center to lead a regional effort to investigate a lung disease that claims almost as many lives as breast cancer - and strikes smokers and non-smokers.
Researchers will work with idiopathic pulmonary fibrosis patients. IPF involves scarring of the lungs, which reduces the amount of oxygen delivered to the bloodstream. An estimated 30,000 patients are diagnosed with IPF each year, and Tulane experts say the annual IPF fatality rate is reaching 45,000 - the same number of deaths attributed to breast cancer each year. (Copyright 2005 Dolan Media Newswires)
Source: New Orleans CityBusiness
Related Articles
- Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
- Large Clinical Trial Shows Pirfenidone Could help Lung Function In IPF Patients
- InterMune Announces Progress on Pirfenidone in IPF
- InterMune Completes Patient Enrollment in Phase 3 'Capacity' Program Evaluating Pirfenidone in Patients With IPF
- Coalition for Pulmonary Fibrosis and American Thoracic Society Award $100,000 Pulmonary Fibrosis Grant to Johns Hopkins Researcher
- Coalition for Pulmonary Fibrosis Concludes Successful National IPF Awareness Week
- Coalition for Pulmonary Fibrosis Partners With American Thoracic Society to Jointly Fund $100,000 IPF Research Grant
- Coalition for Pulmonary Fibrosis Provides $43,000 Gift to The University of Chicago to Advance New Approaches to Understanding IPF
- First-Time National Poll on IPF Reveals Disorder's Prevalence Far Greater Than Its Public Awareness
- 350,000-Year-Old Footprints Discovered
 |
 |
User Comments (0)
RSS Feeds